X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders

By Tina Stow  |    July 13, 2015
It’s hard to imagine, but there are currently more than 50 million Americans – nearly one-sixth of our population – affected by some type of neurological disorder. While some of these are more...   Read More

New Evidence of Discrimination in Essential Health Benefit Plans

By Tina Stow  |    January 30, 2015
While the Affordable Care Act (ACA) expanded access to health insurance coverage for millions, a new study from the Harvard T.H. Chan School of Public Health reveals that insurers may be...   Read More

Burden on Patients: One-Size-Fits-All Approach to Treating Multiple Sclerosis Hurts Patients

By Allyson Funk  |    July 2, 2014
Recently, we discussed the obstacles patients face in managing chronic conditions such as mental health disorders, HIV/AIDS and Rheumatoid Arthritis under the Affordable Care Act’s health...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates